Table of Contents Table of Contents
Previous Page  7 / 226 Next Page
Information
Show Menu
Previous Page 7 / 226 Next Page
Page Background

Ted Hadfield, PhD

Owner, Hadeco LLC.

SPADA BACILLUS ANTHRACIS WORKING GROUP CO-CHAIR

Ted L. Hadfield, Ph.D., Co-chair of the Variols Working Group, graduated from University of Utah in

1976. He did a post doctoral in Clinical Immunology at the Latter Day Saints Hospital in Salt Lake City,

UT. He subsequently was an assistant professor at California State University in Los Angeles. In 1980 he

joined the United States Air Force as a Laboratory Officer. He was stationed at the Armed Forces

Institute of Pathology as Chief of Bacteriology. In 1984 he was transferred to Wilford Hall USAF Medical

Center in San Antonio Texas as Chief, Clinical Microbiology. In 1989, he transferred back to the Armed

Forces Institute of Pathology as Chief of Microbiology. Dr. Hadfield retired from the Air Force in 2000

and was appointed as a Distinguished Scientist at the American Registry of Pathology. He continued as

Chief of Microbiology and as Deputy Director of Infectious and Parasitic Diseases Pathology. In 2003 he

moved to MRIGlobal’s Florida Division as Chief, Bioscience Advisor. In 2012 he retired from MRIGlobal

and became president of HADECO, LLC, a consultation service for microbiological, immunology and

molecular biology solutions. Dr Hadfield has more than 100 scientific publications and remains active in

research projects at MRIGlobal, University of Florida, Gainesville and consultations with clinical

laboratories.

Jay E. Gee, PhD

Research Biologist, Bacterial Special Pathogens Branch, DHCPP, NCEZID

United States Centers for Disease Control and Prevention

SPADA

BURKHOLDERIA PSEUDOMALLEI

WORKING GROUP CHAIR

Jay E. Gee earned his BS in Microbiology at Mississippi State University in 1987 and his PhD in

Biochemistry in 1992 at the University of Alabama at Birmingham School of Medicine. He studied

antisense oligonucleotide technology in his first postdoctoral position at Baylor College of Medicine in

Houston, TX. He later studied antiviral therapy strategies using chemically modified oligonucleotides in a

vesicular stomatitis virus model at L’Institut de Génétique Moléculaire de Montpellier (The Institute of

Molecular Genetics of Montpellier) in France in a second postdoctoral position.

He has been with the CDC for almost 14 years. During his research at CDC, he designed real-time PCR

assays to identify pathogenic

Leptospira

spp. and

Burkholderia pseudomallei

and has performed

molecular genetic subtyping on a variety of pathogens such as

Bacillus

spp. (e.g.

B. anthracis

and

B.

cereus

) and

Burkholderia

spp. (e.g.

B. pseudomallei

and

B. mallei

) in support of epidemiological case

investigations. He has served on the CDC Environmental Microbiology Work Group and serves on the

CDC Next Generation Sequencing Quality Workgroup. He is currently a subject matter expert on

Burkholderia pseudomallei

and

B. mallei

.